"For the next two hours, the executives worked in groups, pretending to be one of Merck's top competitors. Energy soared as they developed ideas for drugs that would crush theirs and key markets they had missed. Then, their challenge was to reverse their roles and figure out how to defend against these threats.* This "kill the company" exercise is powerful because it reframes a gain-framed activity in terms of losses."